Webinar Series

Pathogen Reduction of Platelet Concentrates

In this series of webinars, experts examine in vitro and in vivo performance of products treated with the Mirasol® Pathogen Reduction Technology (PRT) System, based on literature review and their own clinical experience. Gain an understanding of Mirasol capabilities with respect to the in vitro functional assay, pathogen log reduction and clinical performance.


Watch one or all sessions on demand.





Impact of Different PRTs on the Biochemistry, Function and Effectiveness of Platelet Concentrates

Dr. Escolar discusses the need for PRT and provides a detailed comparison of how three different available technologies impact the biochemistry and function of platelets for transfusion.


26 minutes




Gines Escolar, MD, PhD

Department of Pathology Laboratory of Hemostasis, Hospital Clinic, Barcelona, Spain





What have we learned from randomized clinical trials of pathogen reduction technologies?

Dr. McCullough explains how PRT platelet quality is evaluated and shares his conclusions from a review of both randomized, controlled trials and observational studies of PRT platelet performance.


22 minutes




Jeffrey McCullough, MD

Emeritus Professor, Department of Laboratory Medicine and Pathology, University of Minnesota, USA

Defining Adequate Levels of Pathogen Reduction

Dr. Goodrich examines “how much is enough” and the need to balance effective pathogen reduction against the cell and protein damage induced by the process.

36 minutes




Raymond P. Goodrich, PhD

Director of the Infectious Disease Research Center (IDRC), Colorado State University, USA





Roundtable With Dr. Jeffrey McCullough, MD, and Clinicians

With Dr. McCullough as moderator, practitioners from three different blood centers share their clinical experience with PRT platelets.


24 minutes